These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36894369)

  • 1. Reprint of: de novo neuroendocrine features in prostate cancer.
    Abdulfatah E; Fine SW; Lotan TL; Mehra R
    Hum Pathol; 2023 Mar; 133():115-125. PubMed ID: 36894369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo neuroendocrine features in prostate cancer.
    Abdulfatah E; Fine SW; Lotan TL; Mehra R
    Hum Pathol; 2022 Sep; 127():112-122. PubMed ID: 35810832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Aggressive variants of castration resistant prostate cancer (CRPC): neuroendocrine prostate cancer.].
    Quicios-Dorado C; Bolufer-Moragues E; Gomis-Goti C; Cabello-Benavente R; Cannata-Ortiz PJ; González-Enguita C
    Arch Esp Urol; 2018 Sep; 71(8):721-734. PubMed ID: 30319132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine tumors of the prostate.
    Fine SW
    Mod Pathol; 2018 Jan; 31(S1):S122-132. PubMed ID: 29297494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine Tumors of the Prostate: Emerging Insights from Molecular Data and Updates to the 2016 World Health Organization Classification.
    Priemer DS; Montironi R; Wang L; Williamson SR; Lopez-Beltran A; Cheng L
    Endocr Pathol; 2016 Jun; 27(2):123-35. PubMed ID: 26885643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Open University's first one-day symposium on treatment-emergent neuroendocrine prostate cancer.
    Mather RL; Andrews H; Pandha H; Jachetti E; Micallef J; Wang Y; Crea F
    Future Oncol; 2020 Feb; 16(6):147-149. PubMed ID: 31964195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving concepts in prostatic neuroendocrine manifestations: from focal divergent differentiation to amphicrine carcinoma.
    Bellur S; Van der Kwast T; Mete O
    Hum Pathol; 2019 Mar; 85():313-327. PubMed ID: 30481509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and molecular features of treatment-related neuroendocrine prostate cancer.
    Akamatsu S; Inoue T; Ogawa O; Gleave ME
    Int J Urol; 2018 Apr; 25(4):345-351. PubMed ID: 29396873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large Cell Neuroendocrine Carcinoma of the Prostate: A Systematic Review and Pooled Analysis.
    Tu X; Chang T; Nie L; Qiu S; Xu H; Huang Y; Bao Y; Liu Z; Yang L; Wei Q
    Urol Int; 2019; 103(4):383-390. PubMed ID: 30965328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, pathologic, and molecular features of amphicrine prostate cancer.
    Graham LS; Haffner MC; Sayar E; Gawne A; Schweizer MT; Pritchard CC; Coleman I; Nelson PS; Yu EY
    Prostate; 2023 May; 83(7):641-648. PubMed ID: 36779357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuroendocrine prostate cancer: Natural history, molecular features, therapeutic management and future directions].
    Campedel L; Kossaï M; Blanc-Durand P; Rouprêt M; Seisen T; Compérat E; Spano JP; Malouf G
    Bull Cancer; 2017 Sep; 104(9):789-799. PubMed ID: 28673439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current and emerging therapies for neuroendocrine prostate cancer.
    Alabi BR; Liu S; Stoyanova T
    Pharmacol Ther; 2022 Oct; 238():108255. PubMed ID: 35905791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary Prostatic Carcinoma With De Novo Diffuse Neuroendocrine Differentiation.
    Galea LA; Mow C; Fine SW; Manohar P
    Int J Surg Pathol; 2022 Apr; 30(2):232-236. PubMed ID: 34338584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine and paracrine characteristics of neuroendocrine prostate cancer.
    Arman T; Nelson PS
    Front Endocrinol (Lausanne); 2022; 13():1012005. PubMed ID: 36440195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporting Trends, Practices, and Resource Utilization in Neuroendocrine Tumors of the Prostate Gland: A Survey among Thirty-Nine Genitourinary Pathologists.
    Mohanty SK; Lobo A; Williamson SR; Shah RB; Trpkov K; Varma M; Sirohi D; Aron M; Kandukari SR; Balzer BL; Luthringer DL; Ro J; Osunkoya AO; Desai S; Menon S; Nigam LK; Sardana R; Roy P; Kaushal S; Midha D; Swain M; Ambekar A; Mitra S; Rao V; Soni S; Jain K; Diwaker P; Pattnaik N; Sharma S; Chakrabarti I; Sable M; Jain E; Jain D; Samra S; Vankalakunti M; Mohanty S; Parwani AV; Sancheti S; Kumari N; Jha S; Dixit M; Malik V; Arora S; Munjal G; Gopalan A; Magi-Galluzzi C; Dhillon J
    Int J Surg Pathol; 2023 Sep; 31(6):993-1005. PubMed ID: 35946087
    [No Abstract]   [Full Text] [Related]  

  • 16. A highly-specific fully-human antibody and CAR-T cells targeting CD66e/CEACAM5 are cytotoxic for CD66e-expressing cancer cells in vitro and in vivo.
    Baek DS; Kim YJ; Vergara S; Conard A; Adams C; Calero G; Ishima R; Mellors JW; Dimitrov DS
    Cancer Lett; 2022 Jan; 525():97-107. PubMed ID: 34740610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroendocrine differentiation in castration resistant prostate cancer. Nuclear medicine radiopharmaceuticals and imaging techniques: A narrative review.
    Usmani S; Orevi M; Stefanelli A; Zaniboni A; Gofrit ON; Bnà C; Illuminati S; Lojacono G; Noventa S; Savelli G
    Crit Rev Oncol Hematol; 2019 Jun; 138():29-37. PubMed ID: 31092382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Biological Features of Neuroendocrine Prostate Cancer.
    Yamada Y; Beltran H
    Curr Oncol Rep; 2021 Jan; 23(2):15. PubMed ID: 33433737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of neuroendocrine prostate carcinoma: Literature review].
    Yossi S; Brahmi T; Enachescu C; Selmaji I; Lapierre A; Samlali H; Chapet O
    Cancer Radiother; 2016 Jun; 20(4):330-5. PubMed ID: 27340027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doublecortin Expression in Prostate Adenocarcinoma and Neuroendocrine Tumors.
    Tabrizi S; Alshalalfa M; Mahal BA; Davicioni E; Liu Y; Mouw KW; Feng F; Nguyen PL; Muralidhar V
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(4):936-940. PubMed ID: 32585335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.